Haruka Iwao

949 total citations
22 papers, 472 citations indexed

About

Haruka Iwao is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Haruka Iwao has authored 22 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Haruka Iwao's work include Multiple Myeloma Research and Treatments (4 papers), Acute Myeloid Leukemia Research (2 papers) and IgG4-Related and Inflammatory Diseases (2 papers). Haruka Iwao is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Acute Myeloid Leukemia Research (2 papers) and IgG4-Related and Inflammatory Diseases (2 papers). Haruka Iwao collaborates with scholars based in Japan and China. Haruka Iwao's co-authors include Hisanori Umehara, Akio Nakajima, Yasufumi Masaki, Tomoyuki Sakai, Masao Tanaka, Miyuki Miki, Yoshimasa Fujita, Toshioki Sawaki, Toshihiro Fukushima and Takafumi Kawanami and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Haruka Iwao

22 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruka Iwao Japan 12 149 139 113 107 104 22 472
Miyuki Miki Japan 11 108 0.7× 123 0.9× 73 0.6× 72 0.7× 68 0.7× 20 363
J.E. Kurtz France 14 53 0.4× 203 1.5× 94 0.8× 64 0.6× 107 1.0× 34 543
Toshio Kakihara Japan 12 39 0.3× 110 0.8× 89 0.8× 19 0.2× 164 1.6× 47 410
Paola Cagnati Italy 10 93 0.6× 94 0.7× 76 0.7× 51 0.5× 60 0.6× 11 436
Yasuo Matsuoka Japan 12 142 1.0× 27 0.2× 37 0.3× 66 0.6× 85 0.8× 49 402
M.R. Persey United Kingdom 6 102 0.7× 88 0.6× 130 1.2× 72 0.7× 563 5.4× 13 658
Rebecca Hasseli Germany 10 136 0.9× 67 0.5× 23 0.2× 35 0.3× 66 0.6× 26 341
Terumasa Hisano Japan 11 61 0.4× 153 1.1× 207 1.8× 61 0.6× 105 1.0× 30 431
Shunli Tang China 11 98 0.7× 38 0.3× 47 0.4× 87 0.8× 110 1.1× 24 496
Daniel Ching Australia 11 74 0.5× 62 0.4× 101 0.9× 46 0.4× 144 1.4× 28 429

Countries citing papers authored by Haruka Iwao

Since Specialization
Citations

This map shows the geographic impact of Haruka Iwao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruka Iwao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruka Iwao more than expected).

Fields of papers citing papers by Haruka Iwao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruka Iwao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruka Iwao. The network helps show where Haruka Iwao may publish in the future.

Co-authorship network of co-authors of Haruka Iwao

This figure shows the co-authorship network connecting the top 25 collaborators of Haruka Iwao. A scholar is included among the top collaborators of Haruka Iwao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruka Iwao. Haruka Iwao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fujita, Yoshimasa, Takao Fujii, Tomomi Sato, et al.. (2016). Isolation of vascular smooth muscle antigen-reactive CD4+αβTh1 clones that induce pulmonary vasculitis in MRL/Mp-Fas mice. Cellular Immunology. 303. 50–54. 1 indexed citations
3.
Minato, Hiroshi, Eriko Kinoshita, Satoko Nakada, et al.. (2015). Thymic lymphoid hyperplasia with multilocular thymic cysts diagnosed before the Sjögren syndrome diagnosis. Diagnostic Pathology. 10(1). 103–103. 12 indexed citations
4.
Masaki, Yasufumi, Akio Nakajima, Haruka Iwao, et al.. (2013). Japanese Variant of Multicentric Castleman's Disease Associated With Serositis and Thrombocytopenia ^|^mdash; A Report of Two Cases: Is TAFRO Syndrome (Castleman- Kojima Disease) a Distinct Clinicopathological Entity?. Journal of Clinical and Experimental Hematopathology. 53(1). 79–85. 72 indexed citations
5.
Dong, Lingli, Ken Watanabe, M Itoh, et al.. (2012). CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice. International Immunology. 24(5). 327–337. 35 indexed citations
6.
Fukushima, Toshihiro, Tomomi Sato, Takuji Nakamura, et al.. (2012). Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.. PubMed. 32(12). 5437–40. 11 indexed citations
7.
Kawanami, Takafumi, Toshioki Sawaki, Tomoyuki Sakai, et al.. (2012). Skewed Production of IL-6 and TGFβ by Cultured Salivary Gland Epithelial Cells from Patients with Sjögren's Syndrome. PLoS ONE. 7(10). e45689–e45689. 23 indexed citations
8.
Fukushima, Toshihiro, Haruka Iwao, Tomoyuki Sakai, et al.. (2012). [Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma - a case report].. PubMed. 39(5). 805–7. 2 indexed citations
9.
Fukushima, Toshihiro, Hiroshi Kawabata, Toshioki Sawaki, et al.. (2012). Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.. PubMed. 32(4). 1347–53. 9 indexed citations
10.
Masaki, Yasufumi, Haruka Iwao, Akio Nakajima, et al.. (2011). IgG4-Related Disease (IgG4+MOLPS) – Diagnostic Criteria and Diagnostic Problems. Current Immunology Reviews. 7(2). 172–177. 4 indexed citations
11.
Iwao, Haruka, et al.. (2011). A case of Castleman disease with status epileptics originating from focal cortical dysplasia. Rinsho Shinkeigaku. 51(7). 487–492. 1 indexed citations
12.
Masaki, Yasufumi, Miyuki Miki, Takuji Nakamura, et al.. (2011). High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma. International Journal of Hematology. 93(6). 720–726. 13 indexed citations
13.
Fukushima, Toshihiro, Hiroshi Kawabata, Takuji Nakamura, et al.. (2011). Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia.. PubMed. 31(5). 1741–4. 54 indexed citations
14.
Miki, Miyuki, Yasufumi Masaki, Takuji Nakamura, et al.. (2010). [Primary neurolymphomatosis of the cervical nerve root].. PubMed. 51(7). 564–7. 2 indexed citations
15.
Sato, Yasuharu, Masaru Kojima, Katsuyoshi Takata, et al.. (2010). Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. Journal of Clinical Pathology. 63(12). 1084–1089. 95 indexed citations
16.
Fukushima, Toshihiro, Takuji Nakamura, Miyuki Miki, et al.. (2010). Complete response obtained by bortezomib plus dexamethasone in a patient with relapsed multiple myeloma with multiple plasmacytomas.. PubMed. 30(9). 3791–4. 5 indexed citations
17.
Cao, Yan, Zhe-Xiong Jin, Xiaopeng Tong, et al.. (2010). Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis.. PubMed. 30(10). 3911–7. 8 indexed citations
18.
Jin, Zhe-Xiong, Lingli Dong, Xiaopeng Tong, et al.. (2010). Cisplatin augments FAS-mediated apoptosis through lipid rafts.. PubMed. 30(6). 2065–71. 23 indexed citations
19.
Fukushima, Toshihiro, Haruka Iwao, Miyuki Miki, et al.. (2009). MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy.. PubMed. 29(8). 3361–4. 7 indexed citations
20.
Hara, Toshiro, et al.. (1991). High‐Dose Intravenous Gammaglobulin Therapy for Neonatal Immune Haemolytic Jaundice due to Blood Group Incompatibility. Acta Paediatrica. 80(2). 163–166. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miyuki Miki Breakdown of academic impact, for papers by J.E. Kurtz Breakdown of academic impact, for papers by Toshio Kakihara Breakdown of academic impact, for papers by Paola Cagnati Breakdown of academic impact, for papers by Yasuo Matsuoka Breakdown of academic impact, for papers by M.R. Persey Breakdown of academic impact, for papers by Rebecca Hasseli Breakdown of academic impact, for papers by Terumasa Hisano Breakdown of academic impact, for papers by Shunli Tang Breakdown of academic impact, for papers by Daniel Ching
Rankless by CCL
2026